Research programs

Cima is structured in three main research divisions and 10 programs that integrate the scientific activity carried out by the different research groups. The scientific work of our researchers is supported by the Technological Platforms.

This solid organizational model reinforces the functional collaboration of multidisciplinary scientific teams working with a translational approach in the integral approach to diseases.

Our research programs

Access the programs that integrate our main research divisions


  • Gene Therapy in Rare Diseases Program

  • Gene Therapy in Neurological Diseases Program

  • RNA Biology and Therapies Program

Learn more about our research

Get to know our research and research and technological support units

<p>Fachada del Centro de Investigaci&oacute;n M&eacute;dica Aplicada (CIMA)</p>

Support our science?

Thanks to the generosity of many people, the Cima University of Navarra is a reality
that strives to offer therapeutic solutions to achieve personalized medicine for patients.

Transversal programs

Research linked to the scientific activity of the vertical programs, enhancing the knowledge of these scientific areas in a novel integrated approach to the diseases we investigate.

Computational Biology Program

Focused on the development and application of computational methods to improve the diagnosis, prevention and treatment of the diseases we research in the context of personalized medicine.

Immunology and Immunotherapy Program

We develop new therapeutic tools and strategies based on the modulation of the immune system to treat different types of cancers and infectious diseases.

Regenerative Medicine Program

We study the biological mechanisms of stem cells for their therapeutic application in different diseases. Knowing the regenerative potential of these cells, we develop new products for advanced therapies.

Gene Therapy Program
and Regulation of Gene Expression

We advance molecular knowledge of the human genome to develop efficient and safe gene therapy vectors to identify new therapeutic targets and new treatments for severe diseases that currently lack satisfactory treatment.

Molecular Therapies Program

We use the new molecular targets and mechanisms discovered by our researchers in the design and validation of new therapeutic molecules of clinical interest aimed at covering unresolved medical needs.